Pages that link to "Q44252156"
Jump to navigation
Jump to search
The following pages link to A comparison of the fixed combination of latanoprost and timolol with its individual components (Q44252156):
Displaying 50 items.
- Neuroprotection for treatment of glaucoma in adults (Q24200657) (← links)
- Interventions for age-related visual problems in patients with stroke (Q24201153) (← links)
- Neuroprotection for treatment of glaucoma in adults (Q24240024) (← links)
- Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus (Q26830201) (← links)
- Neuroprotection for treatment of glaucoma in adults. (Q30238789) (← links)
- Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products (Q30588260) (← links)
- Use of fixed-dose combination drugs for the treatment of glaucoma (Q33306097) (← links)
- Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database (Q33398724) (← links)
- Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination (Q33546682) (← links)
- Considerations in glaucoma therapy: fixed combinations versus their component medications. (Q33644139) (← links)
- Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: A prospective, observational, noninterventional study (Q33687798) (← links)
- Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension (Q33857744) (← links)
- Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension (Q33996251) (← links)
- Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension (Q34043309) (← links)
- Latanoprost : an update of its use in glaucoma and ocular hypertension (Q34204360) (← links)
- Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate (Q34606706) (← links)
- Clinical options for the reduction of elevated intraocular pressure (Q34708267) (← links)
- A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components (Q34737181) (← links)
- Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysis (Q35370679) (← links)
- A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension (Q35591747) (← links)
- A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe (Q35592180) (← links)
- An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension (Q35753429) (← links)
- Effect of latanoprost/timolol and dorzolamide/tiomolol on intraocular pressure after phacoemulsification surgery (Q35923897) (← links)
- Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy (Q36044733) (← links)
- Current and emerging medical therapies for glaucoma (Q36066033) (← links)
- Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model (Q36920000) (← links)
- Pharmacological management of primary open-angle glaucoma: second-line options and beyond (Q37253030) (← links)
- Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects (Q37555451) (← links)
- Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review (Q37577392) (← links)
- Preservative Use in Topical Glaucoma Medications (Q37905989) (← links)
- A review of the use of latanoprost for glaucoma since its launch (Q37986149) (← links)
- Intraocular pressure-lowering combination therapies with prostaglandin analogues (Q38017728) (← links)
- Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma (Q38018840) (← links)
- Latanoprost/timolol fixed combination for the treatment of glaucoma. (Q38117401) (← links)
- Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost (Q41823074) (← links)
- Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg (Q41939266) (← links)
- Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature (Q42029736) (← links)
- The role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials (Q42789677) (← links)
- Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs (Q42921266) (← links)
- 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma (Q42961737) (← links)
- Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension (Q44849772) (← links)
- 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol. (Q46032736) (← links)
- Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients (Q46554989) (← links)
- Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension (Q46684073) (← links)
- Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension (Q46739178) (← links)
- Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis. (Q53639813) (← links)
- Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension (Q59698052) (← links)
- [Practical measures. Advantages of fixed combination treatments] (Q79314032) (← links)
- Effects of topical antiglaucoma medications on the ocular surface (Q79387442) (← links)
- Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components (Q80482541) (← links)